Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis.

Fleischmann, Roy; Alam, Jahangir; Arora, Vipin; Bradley, John; Schlichting, Douglas E; Muram, David; Smolen, Josef S

Fleischmann, Roy; Alam, Jahangir; Arora, Vipin; Bradley, John; Schlichting, Douglas E; Muram, David; Smolen, Josef S.

Afiliação

Fleischmann R; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Alam J; Eli Lilly and Company, Indianapolis, Indiana, USA.
Arora V; Eli Lilly and Company, Indianapolis, Indiana, USA.
Bradley J; Eli Lilly and Company, Indianapolis, Indiana, USA.
Schlichting DE; Eli Lilly and Company, Indianapolis, Indiana, USA.
Muram D; Eli Lilly and Company, Indianapolis, Indiana, USA.
Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.

RMD Open ; 3(2): e000546, 2017.

Article em En | MEDLINE | ID: mdl-29071120

Palavras-chave

DMARDs (biologic); rheumatoid rrthritis; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article